Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles

Pharmaceutical Research

Volumn 26, Issue 9, 2009, Pages 2164-2173

  Gou, Maling ^a   Zheng, Xiuling ^a   Men, Ke ^a   Zhang, Juan ^a   Wang, Bilan ^a   Lv, Lei ^a   Wang, Xiuhong ^a   Zhao, Yinlan ^a   Luo, Feng ^a   Chen, Lijuan ^a   Zhao, Xia ^a   Wei, Yuquan ^a   Qian, Zhiyong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Honokiol; Micelle; MPEG PCL; Nanomedicine; Self assembly

Indexed keywords

COPOLYMER; HONOKIOL; MACROGOL; ORGANIC SOLVENT; POLYCAPROLACTONE; SELF ASSEMBLED MONOLAYER; SURFACTANT;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; EX VIVO STUDY; FEMALE; FREEZE DRYING; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MALE; MICELLE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ULTRASOUND;

ANIMALS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; X-RAY DIFFRACTION;

EID: 68149183600     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9929-8     Document Type: Article

References (46)

1. CM Teng CC Chen FN Ko LG Lee TF Huang YP Chen 1998 Two antiplatelet agents from Magnolia officinalis Thromb Res 50 757 65
2. KT Liou YC Shen CF Chen CM Tsao SK Tsai 2003 The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production Eur J Pharmacol 475 19 27
3. YC Lo YC CM Teng CF Chen CC Chen CY Hong 1994 Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation Biochem Pharmacol 47 549 53
4. KT Liou SM Lin SS Huang CL Chih SK Tsai 2003 Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats Planta Med 69 130 4
5. Y Maruyama H Kuribara 2000 Overview of the pharmacological features of honokiol CNS Drug Rev 6 35 44
6. ER Hahm SV Singh 2007 Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity Mol Cancer Ther 6 2686 95
7. B Lee CH Kim SK Moon 2006 Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells FEBS Lett 580 5177 84
8. X Bai F Cerimele M Ushio-Fukai M Waqas PM Campbell B Govindarajan 2003 Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo J Biol Chem 278 35501 7
9. TE Battle J Arbiser DA Frank 2005 The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells Blood 106 690 7
10. ML Sheu SH Liu KH Lan 2007 Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth PLoS ONE 2 e1096
11. T Wang F Chen Z Chen YF Wu XL Xu S Zheng 2004 Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO World J Gastroenterol 10 2205 8
12. KS Ahn G Sethi S Shishodia B Sung JL Arbiser BB Aggarwal 2006 Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-KB activation pathway Mol Cancer Res 4 621 33
13. K Ishitsuka T Hideshima M Hamasaki N Raje S Kumar H Hideshima 2005 Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis Blood 106 1794 800
14. D Xu Q Lu X Hu 2006 Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol Cancer Lett 243 274 80
15. H Luo Q Zhong LJ Chen XR Qi AF Fu HS Yang 2008 Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer J Cancer Res Clin Oncology 134 937 45
16. QQ Jiang LY Fan GL Yang WH Guo WL Hou LJ Chen 2008 Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model BMC Cancer 8 242 9
17. W Hou L Chen G Yang H Zhou Q Jiang Z Zhong 2008 Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models Phytother Res 22 1125 32
18. V Wagner A Dullaart AK Bock A Zweck 2004 The emerging nanomedicine landscape Nat Biotech 24 1211 7
19. JH Parka S Lee JH Kim K Park K Kim IC Kwon 2008 Polymeric nanomedicine for cancer therapy Prog Polym Sci 33 113 37
20. M Ferrari 2005 Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 167 71
21. RF Service 2005 Nanotechnology takes aim at cancer Science 310 1132 4
22. S Ganta H Devalapally A Shahiwala M Amiji 2008 A review of stimuli-responsive nanocarriers for drug and gene delivery J Control Rel 126 187 204
23. X Wang L Yang Z Chen DM Shin 2008 Application of nanotechnology in cancer therapy and imaging CA Cancer J Clin 58 97 110
24. Saffie-Sieverb R, Ogden J, Parry-Billings M. Nanotechnology approaches to solving the problems of poorly water-soluble drugs. Drug Discovery World. 2005;Summer:71-76.
25. VP Torchilin AN Lukyanov Z Gao BP Sternberg 2003 Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs Proc Nat Acad Sci USA 100 6039 44
26. Z Zhang SS Feng 2006 The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles Biomaterials 27 4025 33
27. SY Kim YM Lee DJ Baik JS Kang 2003 Toxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice Biomaterials 24 55 63
28. Y Hu L Zhang Y Cao H Ge X Jiang C Yang 2004 Degradation behavior of poly(ε-caprolactone)-b-poly(ethylene glycol)-b-poly(ε-caprolactone) micelles in aqueous solution Biomacromolecules 4 1756 62
29. ML Gou M Dai XY Li XH Wang CY Gong Y Xie 2008 Preparation and characterization of honokiol nanoparticles J Mater Sci: Mater Med 19 2605 8
30. ML Gou XY Li M Dai CY Gong XH Wang Y Xie 2008 A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel Int J Pharm 359 228 33
31. Gou ML, Gong CY, Zheng XL, Wang XH, Guo G, Chen LJ, et al. Polymeric matrix for drug delivery: honokiol loaded PCL-PEG-PCL nanoparticles in PEG-MPEG-PCL thermo-sensitive hydrogel. J Biomed Mater Res Part A. 2009;In press.
32. XW Wei CY Gong S Shi SZ Fu K Men S Zeng 2009 Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer Int J Pharm 369 170 5
33. L Chen Q Zhang G Yang L Fan J Tang I Garrard 2007 Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography J Chromatogr A 1142 115 22
34. C Shen S Guo C Lu 2008 Degradation behaviors of monomethoxy poly(ethylene glycol)-b-poly(e-caprolactone) nanoparticles in aqueous solution Polym Adv Technol 19 66 72
35. CB Liu CY Gong MJ Huang JW Wang YF Pan YD Zhang 2008 Thermoreversible Gel-Sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions J Biomed Mater Res Part B: Appl Biomater 84B 165 75
36. KK Jette D Law EA Schmitt GS Kwon 2004 Preparation and drug loading of poly(Ethylene Glycol)-block-Poly(ε-Caprolactone) micelles through the evaporation of a cosolvent azeotrope Pharm Res 21 1184 91
37. G Gaucher MH Dufresne VP Sant N Kang D Maysinger JC Leroux 2005 Block copolymer micelles: preparation, characterization and application in drug delivery J Control Rel 109 169 88
38. ML Gou MJ Huang ZY Qian L Yang M Dai XY Li 2007 Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier Growth Factors 25 202 8
39. OC Farokhzad S Jon A Khademhosseini TNT Tran DA LaVan R Langer 2004 Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Res 64 7668 72
40. GS Kwon T Okano 1996 Polymeric micelles as new drug carriers Advan Drug Deliver Rev 21 107 16
41. R Karnik F Gu P Basto C Cannizzaro L Dean W Kyei-Manu 2008 Microfluidic platform for controlled synthesis of polymeric nanoparticles Nano Lett 8 2906 12
42. X Shuai H Ai N Nasongkla S Kim J Gao 2004 Micellar carriers based on block copolymers of poly(q-caprolactone) and poly(ethylene glycol) for doxorubicin delivery J Control Rel 98 415 26
43. JS Lee SJ Hwang DS Lee 2009 Formation of poly(ethylene glycol)-Poly(ε-caprolactone) nanoparticles via nanoprecipitation Macromol Res 17 72 8
44. SY Kim YM Lee HJ Shin JS Kang 2001 Indomethacin-loaded methoxy poly(ethylene glycol)/poly(ε-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats Biomaterials 22 2049 56
45. CY Gong S Shia PW Dong B Kan ML Gou XH Wang XY Li 2009 Synthesis, characterization, degradation, and in vitro drug release behavior of thermosensitive hydrogel based on PEG-PCL-PEG block copolymers Int J Pharm 365 89 99
46. N Tang G Du N Wang C Liu H Hang W Liang 2007 Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin J Natl Cancer Inst 99 1004 15